Cargando…
Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
OBJECTIVES: Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and stric...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390475/ https://www.ncbi.nlm.nih.gov/pubmed/36003759 http://dx.doi.org/10.1016/j.xjon.2021.07.010 |
_version_ | 1784770662994280448 |
---|---|
author | Dreyfus, Gilles D. Essayagh, Benjamin Benfari, Giovanni Dulguerov, Filip Haley, Shelley Rahman Dommerc, Carine Albert, Adelin Enriquez-Sarano, Maurice |
author_facet | Dreyfus, Gilles D. Essayagh, Benjamin Benfari, Giovanni Dulguerov, Filip Haley, Shelley Rahman Dommerc, Carine Albert, Adelin Enriquez-Sarano, Maurice |
author_sort | Dreyfus, Gilles D. |
collection | PubMed |
description | OBJECTIVES: Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and strict long-term echocardiographic follow-up. Thus, we aimed at gathering such a cohort to examine outcomes of patients undergoing DMR surgery following tricuspid surgery guidelines. METHODS: All consecutive patients with isolated DMR 2005-2015 operated on with baseline FTR assessment and tricuspid annulus diameter measurement were identified. Operative complications, postoperative tricuspid regurgitation incidence, and survival were assessed overall and stratified by guideline-based tricuspid annuloplasty (TA) indication (severe FTR or tricuspid annulus diameter ≥40 mm). RESULTS: Among 441 patients with DMR undergoing mitral repair (66 ± 13 years, 30% female, ejection fraction 66 ± 10%, systolic pulmonary artery pressures 39 ± 12 mm Hg) followed 6 [3-9] years, patients with TA (n = 234, 53%) had generally similar presentation versus without TA (n = 207, 47%; all P ≥ .2) except for more atrial fibrillation and larger left ventricle (both P ≥ .0003). Patients with TA showed longer bypass time, more maze procedures (all P ≤ .001), but hospital stay, renal-failure, pacemaker implantation, and operative mortality (overall 0.9%) were comparable (all P ≥ .2). Postoperative incidence of moderate/severe FTR (0% at 1 year) became over time greater among patients without TA (5-year 8% [4%-13%] vs 3% [1%-11%] and 10-year 10% [6%-16%] vs 4% [1%-16%], P = .01). Survival (95% confidence interval) throughout follow-up was 85% (77%-89%) at 10 years, with hazard ratio 0.57 (0.29-1.10), P = .09. for patients with TA versus without. CONCLUSIONS: In this large surgical DMR cohort, guideline-based FTR management was safe and effective. While long-term mortality did not reach significance, postoperative incidence of moderate/severe FTR, overall low, was nevertheless greater in patients who did not appear to require TA at surgery and linked to tricuspid annular dimension. Thus, future multicenter prospective cohorts with long-term follow-up are warranted to re-examine thresholds for TA performance and impact on survival. |
format | Online Article Text |
id | pubmed-9390475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-93904752022-08-23 Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction Dreyfus, Gilles D. Essayagh, Benjamin Benfari, Giovanni Dulguerov, Filip Haley, Shelley Rahman Dommerc, Carine Albert, Adelin Enriquez-Sarano, Maurice JTCVS Open Adult: Tricuspid Valve OBJECTIVES: Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and strict long-term echocardiographic follow-up. Thus, we aimed at gathering such a cohort to examine outcomes of patients undergoing DMR surgery following tricuspid surgery guidelines. METHODS: All consecutive patients with isolated DMR 2005-2015 operated on with baseline FTR assessment and tricuspid annulus diameter measurement were identified. Operative complications, postoperative tricuspid regurgitation incidence, and survival were assessed overall and stratified by guideline-based tricuspid annuloplasty (TA) indication (severe FTR or tricuspid annulus diameter ≥40 mm). RESULTS: Among 441 patients with DMR undergoing mitral repair (66 ± 13 years, 30% female, ejection fraction 66 ± 10%, systolic pulmonary artery pressures 39 ± 12 mm Hg) followed 6 [3-9] years, patients with TA (n = 234, 53%) had generally similar presentation versus without TA (n = 207, 47%; all P ≥ .2) except for more atrial fibrillation and larger left ventricle (both P ≥ .0003). Patients with TA showed longer bypass time, more maze procedures (all P ≤ .001), but hospital stay, renal-failure, pacemaker implantation, and operative mortality (overall 0.9%) were comparable (all P ≥ .2). Postoperative incidence of moderate/severe FTR (0% at 1 year) became over time greater among patients without TA (5-year 8% [4%-13%] vs 3% [1%-11%] and 10-year 10% [6%-16%] vs 4% [1%-16%], P = .01). Survival (95% confidence interval) throughout follow-up was 85% (77%-89%) at 10 years, with hazard ratio 0.57 (0.29-1.10), P = .09. for patients with TA versus without. CONCLUSIONS: In this large surgical DMR cohort, guideline-based FTR management was safe and effective. While long-term mortality did not reach significance, postoperative incidence of moderate/severe FTR, overall low, was nevertheless greater in patients who did not appear to require TA at surgery and linked to tricuspid annular dimension. Thus, future multicenter prospective cohorts with long-term follow-up are warranted to re-examine thresholds for TA performance and impact on survival. Elsevier 2021-07-20 /pmc/articles/PMC9390475/ /pubmed/36003759 http://dx.doi.org/10.1016/j.xjon.2021.07.010 Text en © 2021 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Adult: Tricuspid Valve Dreyfus, Gilles D. Essayagh, Benjamin Benfari, Giovanni Dulguerov, Filip Haley, Shelley Rahman Dommerc, Carine Albert, Adelin Enriquez-Sarano, Maurice Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
title | Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
title_full | Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
title_fullStr | Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
title_full_unstemmed | Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
title_short | Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
title_sort | outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction |
topic | Adult: Tricuspid Valve |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390475/ https://www.ncbi.nlm.nih.gov/pubmed/36003759 http://dx.doi.org/10.1016/j.xjon.2021.07.010 |
work_keys_str_mv | AT dreyfusgillesd outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT essayaghbenjamin outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT benfarigiovanni outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT dulguerovfilip outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT haleyshelleyrahman outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT dommerccarine outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT albertadelin outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection AT enriquezsaranomaurice outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection |